methotrexate has been researched along with Spondylarthropathies in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (50.00) | 29.6817 |
| 2010's | 12 (42.86) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Alvaro-Gracia, JM; Diaz-Torne, C; Gomez-Reino, J; Gonzalez-Gay, MA; Manero, J; Pego-Reigosa, JM; Rúa-Figueroa, Í; Sanchez-Piedra, C | 1 |
| Cimaz, R; De Souza, M; Giani, T; Marino, A | 1 |
| Heiligenhaus, A; Rudwaleit, M; Walscheid, K | 1 |
| Campos-Fernandez, C; Castro-Villegas, MC; Cea-Calvo, L; Cuende, E; Del Pino-Montes, J; Diaz-Gonzalez, F; Garcia-Magallon, B; Gómez-Reino, JJ; Hernandez, MV; Manero, J; Manrique, S; Martin-Domenech, R; Ruiz-Montesinos, D; Sanchez-Alonso, F; Sanchez-Piedra, C | 1 |
| Agewall, S; Deyab, G; Førre, Ø; Hjeltnes, G; Hokstad, I; Hollan, I; Lyberg, T; Mollnes, TE; Wang Fagerland, M | 1 |
| Leoni, S; Pini, P; Venturi, A | 1 |
| López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L | 1 |
| Arromdee, E; Laohapand, C; Tanwandee, T | 1 |
| Rosenbaum, JT | 1 |
| Corr, M; Kehl, AS; Weisman, MH | 1 |
| Di Martino, V; Herbein, G; Prati, C; Toussirot, E; Wendling, D | 1 |
| Amiel, C; Carcelain, G; Gestermann, N; Girauld, I; Ittah, M; Mariette, X; Miceli-Richard, C; Pavy, S; Sellam, J; Urrutia, A; Venet, A | 1 |
| Crawford, GM; Koscielny, V; Maycock, S; McConnachie, A; Pumford, N; Wade, AG | 1 |
| Geborek, P; Jönsson, G; Kapetanovic, MC; Roseman, C; Saxne, T; Truedsson, L | 1 |
| Kapinga, TH; Martens, H; Mosterd, K; Poblete-Gutiérrez, P; Schoonbrood, TH; van Mierlo, PL | 1 |
| Fragny, D; Jachiet, M; Lepajolec, C; Lependu, C; Mariette, X; Seror, R | 1 |
| de Castro, TC; Hilário, MO; Len, C; Terreri, MT | 1 |
| Gause, A; Schnabel, A | 1 |
| Dahlin, J; Sørensen, SF | 1 |
| Apraş, S; Calgüneri, M; Cobankara, V; Ertenli, I; Kiraz, S; Oztürk, MA | 1 |
| Allanore, Y; Batteux, F; Deslandre, CJ; Kahan, A; Sellam, J; Weill, B | 1 |
| O'Donnell, JL; Stamp, LK | 1 |
| Fassl, C; Leeb, BF; Rintelen, B; Sautner, J | 1 |
| Geborek, P; Kapetanovic, MC; Larsson, L; Saxne, T; Sturfelt, G; Truedsson, L | 1 |
| Burmester, GR; Scherer, HU | 1 |
| Jacobs, JW; van Rijthoven, AW | 1 |
| Inman, RD; Stone, M | 1 |
| Daikh, BE; Ritchlin, CT | 1 |
8 review(s) available for methotrexate and Spondylarthropathies
| Article | Year |
|---|---|
Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies.
Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Clinical Trials as Topic; Humans; Methotrexate; Prospective Studies; Retrospective Studies; Spondylarthropathies; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
[Uveitis in spondyloarthritis].
Topics: Administration, Topical; Adrenal Cortex Hormones; Antirheumatic Agents; HLA-B27 Antigen; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Methotrexate; Prognosis; Spondylarthropathies; Sulfasalazine; Tumor Necrosis Factor-alpha; Uveitis, Anterior | 2017 |
Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Arthritis, Psoriatic; Comorbidity; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Spondylarthropathies; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha; Uveitis | 2015 |
Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Autoimmunity; Bone Morphogenetic Proteins; Cytokines; Fibrocartilage; Humans; Interleukin-22; Interleukin-23; Interleukins; Magnetic Resonance Imaging; Methotrexate; Rheumatic Diseases; Rituximab; Spondylarthropathies; Tendinopathy; Thalidomide; Tumor Necrosis Factor-alpha; Versicans | 2016 |
[Rheumatology 2003-part I: research news concerning pathogenesis, epidemiology, diagnosis, and therapy of chronic inflammatory joint diseases].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cells, Cultured; Clinical Trials as Topic; Diagnosis, Differential; Disease Models, Animal; Female; HLA Antigens; Humans; Infliximab; Methotrexate; Middle Aged; Placebos; Polymorphism, Genetic; Pregnancy; Prognosis; Quality of Life; Randomized Controlled Trials as Topic; Rats; Spondylarthropathies; Spondylitis, Ankylosing; Time Factors | 2003 |
[Biologicals in the treatment of rheumatic diseases].
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Child; Clinical Trials, Phase II as Topic; Cohort Studies; Collagen Diseases; Drug Therapy, Combination; Etanercept; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunoconjugates; Immunoglobulin G; Infliximab; Methotrexate; Placebos; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Remission Induction; Rheumatic Diseases; Rituximab; Spondylarthropathies; Spondylitis, Ankylosing; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Recent developments in the therapy of spondyloarthropathies.
Topics: Alleles; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Reactive; Chronic Disease; Ciprofloxacin; Cyclosporine; Double-Blind Method; Drug Combinations; Follow-Up Studies; Forecasting; Glucosamine; Humans; Immunosuppressive Agents; Lymecycline; Meta-Analysis as Topic; Methotrexate; Multicenter Studies as Topic; Placebos; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Spondylarthropathies; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
Recent advances in the treatment of the seronegative spondyloarthropathies.
Topics: Ciprofloxacin; Female; Humans; Male; Mesalamine; Methotrexate; Prognosis; Prohibitins; Randomized Controlled Trials as Topic; Serologic Tests; Severity of Illness Index; Spondylarthropathies; Treatment Outcome; Tumor Necrosis Factor-alpha | 2001 |
4 trial(s) available for methotrexate and Spondylarthropathies
| Article | Year |
|---|---|
Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.
Topics: Adult; Complement Activation; Complement Membrane Attack Complex; Female; Humans; Male; Methotrexate; Middle Aged; Spondylarthropathies; Tumor Necrosis Factor Inhibitors | 2019 |
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibody Formation; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Spondylarthropathies; Streptococcus pneumoniae; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Combination therapies in spondyloarthropathies.
Topics: Adult; Arthritis; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Radiography; Spondylarthropathies; Sulfasalazine; Treatment Outcome | 2004 |
Autoantibody induction in patients with refractory spondyloarthropathy treated with infliximab and methotrexate.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Autoantibodies; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; Spondylarthropathies | 2005 |
16 other study(ies) available for methotrexate and Spondylarthropathies
| Article | Year |
|---|---|
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Hospitalization; Humans; Hydroxychloroquine; Intensive Care Units; Interleukin 1 Receptor Antagonist Protein; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Pandemics; Pneumonia, Viral; Rheumatic Diseases; Rituximab; SARS-CoV-2; Spain; Spondylarthropathies; Tumor Necrosis Factor Inhibitors | 2020 |
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Methotrexate; Middle Aged; Proportional Hazards Models; Registries; Retrospective Studies; Spain; Spondylarthropathies; Tumor Necrosis Factor Inhibitors | 2019 |
A case of acute onset interstitial pneumonitis in patient with spondyloarthropathy.
Topics: Alveolitis, Extrinsic Allergic; Antirheumatic Agents; Female; Humans; Methotrexate; Middle Aged; Spondylarthropathies | 2013 |
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis | 2015 |
Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cross-Sectional Studies; DNA, Viral; Female; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Spondylarthropathies; Time Factors; Viral Load; Virus Activation | 2015 |
Spondyloarthropathy and chronic B hepatitis. Effect of anti-TNF therapy.
Topics: Adenine; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Antiviral Agents; Drug Therapy, Combination; Etanercept; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Immunoglobulin G; Infliximab; Lamivudine; Male; Methotrexate; Organophosphonates; Receptors, Tumor Necrosis Factor; Spondylarthropathies; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load; Virus Activation | 2009 |
Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cross-Sectional Studies; Herpesvirus 4, Human; Humans; Longitudinal Studies; Methotrexate; Middle Aged; Spondylarthropathies; T-Lymphocytes; Tumor Necrosis Factor-alpha; Viral Load | 2009 |
Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Interviews as Topic; Male; Methotrexate; Middle Aged; Online Systems; Psoriasis; Quality of Life; Receptors, Tumor Necrosis Factor; Self Report; Spondylarthropathies; Telephone; Treatment Outcome | 2011 |
Psoriasiform disorders with joint symptoms.
Topics: Arthritis, Psoriatic; Arthritis, Reactive; Dermatologic Agents; Diagnosis, Differential; Doxycycline; Folic Acid; Humans; Male; Methotrexate; Middle Aged; Spondylarthropathies; Treatment Failure | 2011 |
Severe deafness associated with Crohn's disease and spondylarthropathy: successful treatment with anti-TNF.
Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Crohn Disease; Deafness; Drug Therapy, Combination; Glucocorticoids; Hearing Loss, Sensorineural; Humans; Male; Methotrexate; Prednisone; Spondylarthropathies; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2013 |
Treatment of refractory juvenile idiopathic arthritis via pulse therapy using methylprednisolone and cyclophosphamide.
Topics: Adolescent; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Methylprednisolone; Pulse Therapy, Drug; Spondylarthropathies; Treatment Outcome | 2003 |
[Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Humans; Infliximab; Methotrexate; Middle Aged; Spondylarthropathies; Treatment Outcome | 2003 |
HLA-B27 associated spondyloarthropathy, vasculitis, and amyloid enteropathy: response to infliximab.
Topics: Adult; Amyloidosis; Antibodies, Monoclonal; Antirheumatic Agents; Aortitis; Drug Therapy, Combination; Female; Gastroenteritis; HLA-B27 Antigen; Humans; Infliximab; Methotrexate; Prednisone; Spondylarthropathies; Treatment Outcome | 2005 |
Intravenous application of omega-3 fatty acids in a patient with active spondylarthropathy--a case report.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Fatty Acids, Omega-3; Fish Oils; Humans; Injections, Intravenous; Male; Methotrexate; Severity of Illness Index; Spondylarthropathies; Treatment Outcome | 2006 |
Predictors of infusion reactions during infliximab treatment in patients with arthritis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Drug Hypersensitivity; Female; Humans; Infliximab; Infusions, Intravenous; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Predictive Value of Tests; Risk Factors; Spondylarthropathies | 2006 |
[Seronegative spondylarthropathy: variable manifestations, common characteristics].
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Diagnosis, Differential; Female; HLA-B27 Antigen; Humans; Male; Methotrexate; Severity of Illness Index; Spondylarthropathies; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |